Form D · Pharmaceuticals
Innocrin Pharmaceuticals Holdings, LLC
Durham, NC · CIK 0001626547
Offering snapshot reported Jul 13, 2017 · SEC filing
- Reported sold
- $6M Offering amount: $13M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2017 | Initial | $6,000,000 | No comparison | 7 | SEC filing |
| Apr 21, 2015 | Initial | $28,100,000 | No comparison | 9 | SEC filing |
| Dec 11, 2014 | Initial | $8,000,001 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290642
Source: Form D, filed Jul 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fred Eshelman | Director, Executive |
| Richard Kent | Director |
| Thomas Laundon | Executive |
| William Moore | Director, Executive |
| Charles Osborne | Executive |
| Douglas Reed | Director |
| James Rosen | Director |
| Robert Schotzinger | Director |
| S. Edward Torres | Director |
| Andrew Von Eschenbach | Director |
| Steven Weinstein | Director |
| Kristopher Wood | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4505 Emperor Boulevard Suite 300
Durham, NC, 27703
Durham, NC, 27703